Articles

Empowering Development and Enabling Seamless Assay Transfer

Exploratory and preclinical studies often require rapid development of assays. In creating novel immunoassays or providing cellular-based analysis, researchers must proactively plan for a transition to CAP/CLIA or GxP facility for qualification, method validation and implementation. These case studies showcase a number of challenging, high-profile projects supported by the Labcorp Drug Development Translational Biomarker Solutions (Labcorp Drug Development TBS) team.

Filed In

Articles
Biomarkers